Steam recall expanded
This article was originally published in The Tan Sheet
Executive Summary
Nutracoastal Trading expands the voluntary recall of Steam dietary supplements to include lot 90260 because it includes undeclared tadalafil, the active ingredient in the prescription erectile dysfunction drug Cialis. The Freeport, N.Y., company first recalled Steam July 28 after FDA found it included sulfoaildenafil, an anolog of sildenafil, the active ingredient in Viagra (1"The Tan Sheet" Aug. 3, 2009, In Brief)
You may also be interested in...
Double trouble for Nutracoastal
The Freeport, N.Y., company voluntarily recalls two products it markets nationwide as dietary supplements after FDA finds they contain active pharmaceutical ingredients. The Steam supplement was found to have sulfoaildenafil, an analog of the erectile dysfunction drug sildenafil, Nutracoastal Trading and FDA announced July 28. The S-DROL product was found to contain the undeclared steroid desoxymethyltestosterone. FDA said Nutracoastal's steroid-containing tablets are similar to those involved in the agency's warning to American Cellular Labs, but would not confirm whether Nutracoastal's products were linked to any adverse event reports (see story p. 8)
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.